Cervical Dysplasia

Overview

Cervical dysplasia refers to abnormal changes in the cells that line the surface of the cervix, the lower part of the uterus that opens into the vagina. These cells are not cancer, but in some cases they can slowly progress to cervical cancer over many years if they are not monitored or treated. Because of this, cervical dysplasia is described as a precancerous condition.

The medical term most often used is cervical intraepithelial neoplasia, or CIN, which is graded from CIN 1 (mild) to CIN 3 (severe). Another grading system divides changes into low-grade and high-grade squamous intraepithelial lesions. The condition is almost always caused by long-lasting infection with certain high-risk types of human papillomavirus (HPV). Most cases cause no symptoms and are found only through routine screening, which is why regular Pap and HPV testing is so important.

Symptoms

Cervical dysplasia almost never causes noticeable symptoms on its own. This is a key reason that screening exists: the abnormal cells can be present and even advance toward cancer without any outward sign. Most people learn they have dysplasia only after an abnormal Pap or HPV test result.

• Usually no symptoms at all
• Occasionally, light bleeding or spotting between periods or after sex (more often a sign of other cervical problems)
• Unusual vaginal discharge in some cases

Because symptoms are unreliable, you should not wait to feel unwell before being screened. Bleeding after intercourse, bleeding between periods, or bleeding after menopause should always be evaluated by a clinician, since these can signal more advanced cervical disease.

Causes

The overwhelming cause of cervical dysplasia is persistent infection with high-risk types of human papillomavirus, a very common sexually transmitted virus. Most HPV infections clear on their own within one to two years, but when a high-risk type lingers, it can change how cervical cells grow and mature.

• High-risk HPV types: Types 16 and 18 cause most cases of high-grade dysplasia and cervical cancer, though several other types contribute.
• Persistent infection: Dysplasia develops when the virus is not cleared by the immune system and remains active in cervical tissue.

HPV is spread through skin-to-skin and sexual contact and is so common that most sexually active people are exposed at some point. Having dysplasia does not mean someone has been unfaithful or careless; it reflects how widespread HPV is.

Risk Factors

Anything that increases exposure to high-risk HPV or weakens the body's ability to clear it raises the risk of dysplasia.

• Infection with high-risk HPV (the central risk factor)
• Becoming sexually active at a young age or having many sexual partners
• Smoking, which weakens local immune defenses in the cervix
• A weakened immune system, such as from HIV or immune-suppressing medication
• Not being vaccinated against HPV
• Missing or skipping routine cervical screening

Diagnosis

Cervical dysplasia is found and confirmed through a stepwise process that usually begins with routine screening.

• Pap test (cytology): Cells are gently collected from the cervix and examined for abnormal changes.
• HPV testing: The same or a separate sample is tested for high-risk HPV types.
• Colposcopy: If screening is abnormal, a clinician uses a magnifying instrument to examine the cervix closely.
• Biopsy: Small tissue samples are taken during colposcopy and examined under a microscope to confirm the grade of dysplasia.

The grade of dysplasia, the HPV result, and the person's age and history together guide whether to watch and wait or to treat.

Treatment

Treatment depends on how severe the abnormal cells are. Mild changes are often watched closely because they frequently resolve on their own, while moderate to severe changes are usually removed to prevent progression to cancer.

• Active monitoring: CIN 1 (mild dysplasia) is commonly followed with repeat Pap and HPV testing rather than treated, as many cases clear naturally.
• Loop electrosurgical excision procedure (LEEP): A thin wire loop carrying a current removes the abnormal tissue, which can also be examined in a lab.
• Cone biopsy (conization): A cone-shaped piece of cervical tissue is removed for more extensive lesions.
• Ablation: Cryotherapy (freezing) or laser treatment destroys abnormal cells in some cases.

These procedures are highly effective. After treatment, ongoing follow-up testing is essential because dysplasia can sometimes return.

Prevention

• Get the HPV vaccine, which protects against the types that cause most dysplasia and cervical cancer; it works best when given before exposure to the virus
• Keep up with regular cervical screening (Pap and/or HPV testing) on the schedule your clinician recommends
• Do not smoke, since smoking makes it harder to clear HPV
• Use condoms, which lower but do not fully eliminate HPV transmission
• Attend recommended follow-up after any abnormal result or treatment

When to See a Doctor

See a clinician to stay up to date with cervical screening even when you feel completely well, since dysplasia rarely causes symptoms. Contact your clinician promptly if you have:

• Bleeding or spotting between periods
• Bleeding after sex
• Any vaginal bleeding after menopause
• Unusual or persistent vaginal discharge

These symptoms are not emergencies but should be evaluated, as they can indicate more advanced cervical changes that need attention.

Related Topics

Frequently Asked Questions

References

1. National Cancer Institute (NCI). Cervical Cancer Screening.
2. Mayo Clinic. Cervical dysplasia and abnormal Pap results.
3. Centers for Disease Control and Prevention (CDC). Human Papillomavirus (HPV).
4. MedlinePlus, U.S. National Library of Medicine. Cervical dysplasia.